These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4399358)
21. [Adrenergic beta receptor blockaders and nitrites in the treatment of angina pectoris]. Haarmann K; Neff K Schweiz Rundsch Med Prax; 1974 Mar; 63(12):355-9. PubMed ID: 4150716 [No Abstract] [Full Text] [Related]
22. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris. Furberg B; Dahlqvist A; Raak A; Wrege U Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520 [TBL] [Abstract][Full Text] [Related]
23. Double blind trial of propranolol and pindolol in angina pectoris. Ilyas M; Jafary MH; Peracha MA; Janjua M; Khan N J Pak Med Assoc; 1975 Jul; 25(7):165-6. PubMed ID: 815634 [No Abstract] [Full Text] [Related]
24. The effect of beta blockade and-or physical training in patients with angina pectoris. Malmborg RO; Isacsson SO; Kallivroussis G Curr Ther Res Clin Exp; 1974 Mar; 16(3):171-83. PubMed ID: 4150633 [No Abstract] [Full Text] [Related]
25. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris. Sandler G; Clayton GA Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of angina with Amiodarone. Clinical study and double-blind trial]. Oter Rodríguez R; Durate Mantilla G; Vilalta Bernet C; Balaguer Vintró I Rev Clin Esp; 1970 Dec; 119(2):143-8. PubMed ID: 4395739 [No Abstract] [Full Text] [Related]
28. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial. Hickie JB Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977 [No Abstract] [Full Text] [Related]
29. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris. Harston WE; Eff J; Capone P Br J Clin Pract Suppl; 1985 Jun; 40():55-8. PubMed ID: 2864066 [No Abstract] [Full Text] [Related]
30. [Comparative characteristics of the hemodynamic and antianginal actions of obzidan and albetol in patients with stenocardia]. Zaĭtseva VI; Sharaeva ML Vrach Delo; 1988 Dec; (12):15-8. PubMed ID: 2907700 [No Abstract] [Full Text] [Related]
31. [Clinical evaluation of drug efficacy by the double blind method in medicine (author's transl)]. Shimizu N Nihon Naika Gakkai Zasshi; 1976 Jan; 65(1):15-29. PubMed ID: 9459 [No Abstract] [Full Text] [Related]
32. The therapeutic role of propranolol. Fitzgerald JD Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):289-91. PubMed ID: 4391518 [No Abstract] [Full Text] [Related]
37. The influence of sympathicolytics of the electrocardiogram. van Buchem FS; Bosschieter E Proc K Ned Akad Wet C; 1970; 73(1):1-14. PubMed ID: 4392160 [No Abstract] [Full Text] [Related]
38. Comparative study of two beta-adrenergic blocking drugs in angina pectoris. Stroescu V; Theodorini S; Creţescu R Rev Roum Med Intern; 1974; 11(3):307-11. PubMed ID: 4152108 [No Abstract] [Full Text] [Related]
39. A multicentre trial of perhexiline maleate, beta-blocker and placebo in angina pectoris. Armstrong ML; Brand D; Emmett AJ; Hodge JL; Kellaway GS; Mestitz P; Reefman M; Wallace DC Med J Aust; 1974 Sep; 2(11):389-93. PubMed ID: 4154390 [No Abstract] [Full Text] [Related]
40. Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man. Lewis BS; Bakst A; Kitchiner D; Gotsman MS S Afr Med J; 1973 Jul; 47(27):1181-4. PubMed ID: 4146564 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]